Broad Effectiveness: Study With Aripiprazole
Completed · Phase 3
Conditions studied: Schizophrenia, Schizoaffective Disorder
In brief
The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders
Key facts
- Study ID
- NCT00036361
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- People needed
- 444
- Starts
- 2002-07-01
- Expected to finish
- 2003-01-01
- Last updated by the study team
- 2013-11-11
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Local Institution — Wallingford, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.